06:07 EDT Alaunos Therapeutics (TCRT) files $50M mixed securities shelf
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCRT:
- Alaunos Therapeutics Regains Nasdaq Compliance
- Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
- Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
- Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
- Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors